Genprex, Inc. (GNPX) stock
GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.90−0.18 (-8.65%)
Close on Nov 16, 2026Market cap $1.56MP/E –Yield –
Genprex cash
Cash and short-term investments held at the end of each period.
Genprex's cash was $15.15M at Jun 30, 2026. For fiscal 2025 it was $7.83M, up 388.9% from the year before. Over ten years it grew 42.0% a year on average. The highest annual figure on record is $38.63M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.83M | +388.9% |
| FY2024 | Dec 31, 2024 | $1.60M | -76.2% |
| FY2023 | Dec 31, 2023 | $6.74M | -67.8% |
| FY2022 | Dec 31, 2022 | $20.95M | -45.8% |
| FY2021 | Dec 31, 2021 | $38.63M | +41.4% |
| FY2020 | Dec 31, 2020 | $27.32M | +1264.3% |
| FY2019 | Dec 31, 2019 | $2.00M | -76.7% |
| FY2018 | Dec 31, 2018 | $8.60M | +5233.9% |
| FY2017 | Dec 31, 2017 | $161.25K | -89.9% |
| FY2016 | Dec 31, 2016 | $1.60M | +584.1% |
| FY2015 | Dec 31, 2015 | $234.22K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $15.15M | +1025.2% |
| Q1 FY2026 | Mar 31, 2026 | $18.05M | +420.4% |
| Q4 FY2025 | Dec 31, 2025 | $7.83M | +388.9% |
| Q3 FY2025 | Sep 30, 2025 | $1.10M | -25.9% |
| Q2 FY2025 | Jun 30, 2025 | $1.35M | -45.2% |
| Q1 FY2025 | Mar 31, 2025 | $3.47M | -57.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.60M | -76.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.49M | -87.3% |
| Q2 FY2024 | Jun 30, 2024 | $2.46M | -75.3% |
| Q1 FY2024 | Mar 31, 2024 | $8.22M | -54.6% |
| Q4 FY2023 | Dec 31, 2023 | $6.74M | -67.8% |
| Q3 FY2023 | Sep 30, 2023 | $11.71M | -54.1% |
| Q2 FY2023 | Jun 30, 2023 | $9.96M | -66.9% |
| Q1 FY2023 | Mar 31, 2023 | $18.08M | -47.7% |
| Q4 FY2022 | Dec 31, 2022 | $20.95M | -45.8% |
| Q3 FY2022 | Sep 30, 2022 | $25.52M | -39.3% |
| Q2 FY2022 | Jun 30, 2022 | $30.05M | -32.1% |
| Q1 FY2022 | Mar 31, 2022 | $34.56M | -26.6% |
| Q4 FY2021 | Dec 31, 2021 | $38.63M | +41.4% |
| Q3 FY2021 | Sep 30, 2021 | $42.02M | +99.5% |
| Q2 FY2021 | Jun 30, 2021 | $44.24M | +100.0% |
| Q1 FY2021 | Mar 31, 2021 | $47.07M | +103.9% |
| Q4 FY2020 | Dec 31, 2020 | $27.32M | +1264.3% |
| Q3 FY2020 | Sep 30, 2020 | $21.06M | +726.3% |
| Q2 FY2020 | Jun 30, 2020 | $22.13M | +392.1% |
| Q1 FY2020 | Mar 31, 2020 | $23.08M | +232.3% |
| Q4 FY2019 | Dec 31, 2019 | $2.00M | -76.7% |
| Q3 FY2019 | Sep 30, 2019 | $2.55M | -75.3% |
| Q2 FY2019 | Jun 30, 2019 | $4.50M | -62.5% |
| Q1 FY2019 | Mar 31, 2019 | $6.95M | +28267.5% |
| Q4 FY2018 | Dec 31, 2018 | $8.60M | +5233.9% |
| Q3 FY2018 | Sep 30, 2018 | $10.31M | +2657.0% |
| Q2 FY2018 | Jun 30, 2018 | $12.00M | +2464.7% |
| Q1 FY2018 | Mar 31, 2018 | $24.49K | -97.4% |
| Q4 FY2017 | Dec 31, 2017 | $161.25K | -89.9% |
| Q3 FY2017 | Sep 30, 2017 | $373.95K | -61.4% |
| Q2 FY2017 | Jun 30, 2017 | $467.94K | – |
| Q1 FY2017 | Mar 31, 2017 | $930.01K | – |
| Q4 FY2016 | Dec 31, 2016 | $1.60M | – |
| Q3 FY2016 | Sep 30, 2016 | $968.58K | – |
See a number that looks wrong?